IIV4 + PPV23

1 paper1 finding

1 lab in 1 country

Funder: Beijing Municipal Science and Technology Commission

Human trial1

Associations

1

Seroconversion rate

mixedin humans1

1 study

IIV4 + PPV23 is associated with seroconversion rate in humans.
“Furthermore, co-administration of IIV4 and PPV23 affected seroconversion rates for both vaccines.”
Human trialhealthy adults
Immunogenicity and safety of different combinations involving a third booster dose of SARS-CoV-2 inactivated vaccine, inactivated quadrivalent influenza vaccine, and 23-valent pneumococcal polysaccharide vaccine in adults aged ≥60 years: a phase 4, randomized, open-label study
Frontiers in immunologyAug 20, 2024

More on Seroconversion rate

Latest

Frontiers in ImmunologySep 4

Immunogenicity and safety of different combinations involving a third booster dose of SARS-CoV-2 inactivated vaccine, inactivated quadrivalent influenza vaccine, and 23-valent pneumococcal polysaccharide vaccine in adults aged ≥60 years: a phase 4, randomized, open-label study

Randomized trial in 636 peopleInterventions